The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients

NCT04637321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 585

Last updated 2022-02-04

No results posted yet for this study

Summary

2.1. Study Objectives

* Primary Objective(s)
* Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant
* Secondary Objective(s)
* Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant
* Evaluate the impact of CDI on graft survival following Solid Organ Transplant

Conditions

  • Infection in Solid Organ Transplant Recipients

Interventions

PROCEDURE

Solid organ transplant

Data will be collected on all liver, kidney, pancreas and combined transplant recipients who received their graft(s) from April 1, 2015 to July 31, 2018

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Jessica Crotty, PharmD · The Methodist Hospital Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2020-08-07
Completion
2020-08-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637321 on ClinicalTrials.gov